Skip Navigation


Hum. Reprod. Advance Access originally published online on July 14, 2009
Human Reproduction 2009 24(10):2596-2599; doi:10.1093/humrep/dep242
This Article
Right arrow Full Text
Right arrow Full Text (PDF )
Right arrow All Versions of this Article:
24/10/2596    most recent
dep242v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lee, G. H.
Right arrow Articles by Moon, S. Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, G. H.
Right arrow Articles by Moon, S. Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Interleukin-2 receptor β gene C627T polymorphism in Korean women with endometriosis: a case–control study

Gyoung Hoon Lee1, Young Min Choi2,4, Sung Hoon Kim3, Min A. Hong2, Seung Yup Ku2, Seok Hyun Kim2, Jung Gu Kim2 and Shin Yong Moon2

1 Department of Obstetrics and Gynecology, Seoul Medical Center, Seoul, Republic of Korea 2 Department of Obstetrics and Gynecology, The Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea 3 Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

4 Correspondence address. Tel: +82-2-2072-2385; Fax: +82-2-762-3599; E-mail: ymchoi{at}snu.ac.kr

BACKGROUND: The purpose of this study was to investigate the potential association of the C627T polymorphism in the interleukin-2 receptor β gene (IL-2R β) with the risk of endometriosis in Korean women.

METHODS: Two hundred and thirty-seven women with surgically or histologically diagnosed endometriosis of stages III and IV were recruited for this study, and 164 patients with no evidence of endometriosis diagnosed by laparoscopy or laparotomy served as controls. The C627T polymorphism of the IL-2R β was assessed using the TaqMan allelic discrimination assay. {chi}2 analysis was used to examine any differences in genotype distributions and allele frequencies of the IL-2R β C627T polymorphism between the endometriosis cases and the controls.

RESULTS: There was no statistically significant difference in the frequency of the IL-2R β C627T polymorphism between the endometriosis patients and the controls (28.7% C/C, 48.1% C/T and 23.2% T/T versus 29.3, 44.5 and 26.2%, respectively, P = 0.72) or in the T allele frequencies (47.3 versus 48.5%, respectively, P = 0.73). Even when the endometriosis cases were subdivided into stages III and IV, no statistically significant differences in genotype distributions or allele frequencies were observed among the three groups.

CONCLUSIONS: Contrary to the recent data reported in a Taiwanese population, our results suggest that the C627T polymorphism of the IL-2R β gene may not be associated with the risk of endometriosis in the Korean population.

Key words: endometriosis/interleukin-2 receptor β gene/C627T polymorphism/Hardy—Weinburg equilibrium/Korean women

Submitted on January 12, 2009; resubmitted on June 10, 2009; accepted on June 11, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.